Company / Total Assets
Neogen Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$3.4B
FY2025
5-year range
$920.2M / $4.6B
FY2021-FY2025
Trend
-24.3%
vs FY2024
Sector context
#74 of 166
Health Care
What the data says
At $3.4B, Neogen's total assets ranks #74 of 166 in the Health Care sector. Declined from $4.6B to $3.4B over the past 2 years.
Based on SEC 10-K filings.
$3.4B in FY2025 with a 5-year CAGR of +34.0%.
Declined from $4.6B to $3.4B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +51.4%
- 5-Year CAGR
- +34.0%
- 10-Year CAGR
- -
Sector benchmark
#74 of 166 in Health CareTop 45% of 166This company $3.4B Sector average $14.9B
▼
-76.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +34.0%, indicating consistent growth.
- In FY2025, total assets decreased 24.3% year-over-year.
- Ranks #74 out of 166 companies in the Health Care sector.
- Peak total assets was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.4B | -24.3% |
| FY2024 | $4.5B | -0.1% |
| FY2023 | $4.6B | +358.7% |
| FY2022 | $992.9M | +7.9% |
| FY2021 | $920.2M | +15.4% |
| FY2020 | $797.2M | +14.6% |
| FY2019 | $695.7M | +12.6% |
| FY2018 | $618.0M | +17.0% |
| FY2017 | $528.4M | +17.4% |
| FY2016 | $449.9M | +14.7% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026